Pomalidomide desensitization in a patient hypersensitive to immunomodulating agents.
Sign Up to like & getrecommendations! Published in 2017 at "Current oncology"
DOI: 10.3747/co.24.3572
Abstract: Despite progressive treatments with tandem stem-cell transplantation, patients with incurable myeloma eventually succumb to relapsed or refractory disease if left untreated. Promising agents such as proteasome inhibitors and immunomodulating imide drugs (imids), including the newer-generation… read more here.
Keywords: patient hypersensitive; desensitization patient; desensitization; pomalidomide ... See more keywords